nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

28.07.2018 | Letter to the Editor

Could we avoid computing TMTV of DLBCL patients in routine practice?

verfasst von: Eric Laffon, Roger Marthan

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Aide N, Lasnon C, Damaj G. Combining baseline TMTV and gene profiling for a better risk stratification in diffuse large B cell lymphoma. Eur J Nucl Med Mol Imaging. 2018;45:677–9.CrossRefPubMedCentral

Toledano MN, Desbordes P, Banjar A, Gardin I, Vera P, Ruminy P, et al. Combination of baseline FDG PET/CT totalmetabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging 2018;45:680–688.CrossRefPubMedCentral

Ilyas H, Mikhaeel NG, Dunn JT, Rahman F, Møller H, Smith D, et al. Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma. Eur J Nucl Med Mol Imaging. 2018;45:1142–54.CrossRefPubMedCentral

Laffon E, Marthan R. Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory? Eur J Nucl Med Mol Imaging. 2018. https://doi.org/10.1007/s00259-018-4049-5.CrossRef

Ilyas H, Mikhaeel NG, Dunn JT, Rahman F, Møller H, Smith D, et al. Reply to the letter. Eur J Nucl Med Mol Imaging. 2018; https://doi.org/10.1007/s00259-018-4050-z.CrossRefPubMedCentral

Cottereau AS, Buvat I, Kanoun S, Versari A, Casasnovas O, Chauvie S, et al. Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma? Eur J Nucl Med Mol Imaging. 2018;45:1463–4.CrossRefPubMedCentral

Laffon E, Marthan R. On the cutoff of baseline Total metabolic tumor volume in high-tumor-burden follicular lymphoma. J Clin Oncol. 2017;35:919–20.CrossRefPubMedCentral

JCGM. Evaluation of measurement data - guide to the expression of uncertainty in measurement. wwwbipmorg, 2008.

Titel: Could we avoid computing TMTV of DLBCL patients in routine practice?
verfasst von: Eric Laffon
Roger Marthan
Publikationsdatum: 28.07.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 12/2018
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-018-4097-x

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2018

Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?

18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis

Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis

Developing and validating a novel metabolic tumor volume risk stratification system for supplementing non-small cell lung cancer staging

Martin Vahlensieck and Maximilian Reiser (Eds). MRI of the Musculoskeletal System, Second Edition

Feasibility of dynamic stress 201Tl/rest 99mTc-tetrofosmin single photon emission computed tomography for quantification of myocardial perfusion reserve in patients with stable coronary artery disease